Srivani Junoothula 's Insider Trades & SAST Disclosures
No reported Insider Trades available for Srivani Junoothula in the Trendlyne database.
Srivani Junoothula 's has made SAST transactions in Oxygenta Pharmaceutical Ltd. recently where a Acquisition of 500,000 shares done . Disclosure was reported to the exchange on Jan. 5, 2023.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oxygenta Pharma | Kishore Babu Bathula & Srivani Junoothula | Other | Acquisition | 06 Jan 2023 | 500,000 | 500,000 (3.52%) | 3.52% | - | 03 Jan 2023 03 Jan 2023 |
SAST (29(1)) | - | Off Market | |
| Oxygenta Pharma | Srivani Junoothula & Kishore Babu Bathula | Other | Acquisition | 06 Jan 2023 | 380,000 | 380,000 (2.67%) | 2.67% | - | 03 Jan 2023 03 Jan 2023 |
SAST (29(1)) | - | Off Market |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.